By: Edward V. Loftus, Robert Stott, Monica Stonehill
In a Healio video exclusive, Edward V. Loftus Jr., MD , noted that the booming popularity in glucagon-like peptide-1 agonists have spurred an interspecialty “dilemma” regarding aspiration risks in the endoscopy suite.